Patient: Alexander, 50, Russia
Reason for therapy: "Recently, I've been getting tired from frequent flying, and I was having trouble concentrating at work. I decided to try MMSC because of the high workload and the knowledge that it was beneficial."
Therapy: 200 million BM-MSC IV infusion.
Result: "For the first week, I experienced increased drowsiness, then suddenly I stopped feeling tired. This lasted for a couple of weeks, then passed, but my attention and concentration increased. I was able to work more productively. This lasted for eight months. Additionally, my skin stopped drying out in cold climates, I became calmer and more confident, and my joints stopped hurting at the end of long flights."

Patient: B, 42, Russia
Reasons for treatment: "I've suffered from rosacea since adolescence. No matter how many treatments I tried, and even consulted qualified dermatologists and cosmetologists, nothing helped. I was bothered by constant redness, a burning sensation, and discomfort, especially when applying makeup. I also felt extremely tired, had trouble sleeping, and my legs were swollen. I decided to try stem cell therapy."
Therapy: IV infusion and local facial injections of MSCs.
Result: "The redness, burning, and tightness of my skin disappeared, my skin became smooth and velvety, wrinkles diminished, and I felt lighter. My face has remained clear for six months. I have more energy, my sleep has improved, and the swelling in my legs has disappeared. My menstrual cycle has returned to normal. I feel rejuvenated – I have more energy, no pain, and a good mood."

Patient: Philip, 55, Spain
Reasons for therapy: “I've been suffering from insomnia lately. I also had constant fatigue, decreased concentration, and decreased performance. I had liver problems. My knee was also bothering me.”
Therapy: IV infusion and local injections of BM-MSC into the knee.
Result: “My sleep has returned to normal; I'm sleeping like a child. My performance and mood have improved, and my fatigue has decreased. My craving for alcohol has significantly decreased. My liver enzymes (ALT, ALP, GGT) have returned to normal. My digestion has improved—I'm able to digest steaks more easily. My knee has stopped swelling and hurting.”

Patient: Victor, 56, Russia
Reasons for therapy: "I've had bronchial asthma since 1994 and a duodenal ulcer. I fly a lot (over 100 times a year), and after a flight, I had a hard time conducting training and seminars."
Therapy: 200 million BM-MSC IV infusion.
Result: "After three intravenous MMSC injections in 2020, my bronchial asthma disappeared and hasn't bothered me for four years. My ulcer has also stopped bothering me. I feel much better. I had my biological age tested – it turned out to be 14 years younger than my passport age. Also, now I don't feel tired after a flight and can easily conduct training."

Patient: Evgeniya, 40, physician, Russia
Reason for therapy: Decreased performance.
Therapy: IV infusion of the exosomal preparation DC-EX-V (150 trillion exosomes).
Result: "On the third day after exosome administration, I feel great, have lots of energy, and sleep well—I fall asleep and wake up easily. No facial swelling. During exercise, I have excellent joint mobility and virtually no fatigue. My hearing and voice have also improved."

Patient: R, 50, Thailand
Reasons for treatment: Chronic fatigue, burnout syndrome, decreased performance.
Therapy: IV infusion of 200 million bone marrow-derived MSCs.
Results: Two months after the infusion, the patient's biological age was measured (by measuring telomere length in chromosomes). Telomere length increased from 6.662 to 7.460 (by 12%), and biological age decreased from 51 to 43 years (by 8 years). Vigor and performance increased, and fatigue was virtually eliminated.

NEUROLOGY - spinal cord injury
Patient: Vladislav, 21, Russia
Reason for treatment: A car accident involving the thoracic and cervical spine, resulting in a complex fracture of the C3-C6 cervical vertebrae with spinal cord injury. Lower paraplegia (complete loss of motor function and sensation), upper paraparesis (partial loss of motor function and sensation). Surgery was performed to fix the C4-C6 vertebrae.
Cell therapy: 3 intravenous and 1 local injection of DOKAR VITA CELLS donor bone marrow-derived MMSCs, 2 intravenous and 1 local injection of DC-EX exosomes, and DC-EX-N nasal exosomal drops for 2 months.
RESULTS AFTER 3 MONTHS:
- Arm muscle strength has been restored;
- Sensation and movement in the legs have been restored;
- Urination has been restored (prior to treatment, urine was only removed with a catheter);
- Can care for himself (eat, brush his teeth, ride in a wheelchair, open doors);

DIABETES-1
Patient M, 13, Russia
Reasons for therapy: Type 1 diabetes. Daily insulin injections of 65 units. HbA1C 7.9%. Glucose spikes up to 22 (normal 3-6). Constant fatigue and weakness.
Cell therapy: IV MMSC infusion
Results: Stabilization of glucose levels and elimination of spikes. Reduction of daily insulin dosage to 30 units. HbA1C decreased from 7.9 to 6.8%. Improved well-being and performance.

DIABETES-2
Patient Isares, 42, Thailand
Reason for treatment: chronic fatigue, diabetes-2.
Cell therapy: intravenous infusion of MMSCs.
Results: Improved well-being, increased performance, normalization of the CA 19-9 window marker, HbA1c (glycated hemoglobin), and FBS (glucose levels).

DIABETES-2
Patient: Dr. Suthee R., 61, Thailand
Reason for treatment: "Diabetes 2."
Therapy: IV MMSC infusion.
Result: "Before treatment, HbA1c was 6.5%; after 3 months, it was 5.8%. Improved well-being and performance."

DIABETES-2
Patient N, 52, Thailand
Reasons for therapy: Type 2 diabetes. HbA1C 7.2%. Glucose level 202 mg/dL (normal range 70-99). Constant fatigue and weakness.
Cell therapy: IV infusion of 200 million MMSCs on February 7, 2024.
Results: Decreased glucose levels by 22%. HbA1C decreased from 7.2 to 6.1%. Improved well-being and performance. The results lasted for 1 year.

Diabetic nephropathy
Patient Pavel, 43, Russia
Reasons for therapy: Type 2 diabetes. Diabetic nephropathy. Creatinine level - 266 μmol/L.
Cell therapy: IV infusion of 200 million MMSCs on January 12, 2025.
Result: Creatinine level decreased to 217 μmol/L (by 18%) after 16 days. Improved well-being.

NEUROLOGY - spinal cord injury
Patient Nguyen Duc Thinh, 13, Vietnam.
Reasons for treatment: 2022 car accident to the thoracic spine, complex thoracic spine fracture, spinal cord edema from T5 to T12. Displacement of the 7th and 8th thoracic vertebrae, spinal cord hemorrhage, spinal cord compression, and spinal cord injury.
Lower paraplegia (complete loss of motor function and sensation), urinary incontinence, and pulmonary contusion.
Spinal cord decompression surgery and spinal correction using screws and bone grafts were performed.
Cell therapy: Intravenous and local injection of donor bone marrow-derived MMSCs (DOKAR VITA CELLS), intravenous and local injection of the exosomal preparation DC-EX.
Result: After 3 months, sensation in the legs and the urge to urinate returned.
The patient continues exosome treatment.

DIABETES-1
Patient: Eldar, 24, Russia
Reasons for therapy: Type 1 diabetes. Early stages of diabetic nephropathy, retinopathy, and neuropathy. Daily injections of 24 units of insulin. Insulin production was 0.23 (9% of normal), blood glucose was 9 (150% of normal), and HbA1c was 6.37 (120%).
Cell therapy: Three intravenous infusions of 200 million MMSCs, 1 month apart.
Results: Improved well-being and increased performance. Insulin production increased to 1.4 (by 620%), HbA1c decreased. Glucose spikes disappeared.

AUTISM
Patient: Miyabi, 5, Japan.
Autism since age 2. Severe and pervasive deficits in social interaction and communication, restricted interests, repetitive movements and behaviors.
Cell therapy: 3-month course of intravenous infusion of donor bone marrow-derived MSCs and the exosomal product DC-EX.
RESULTS:
Became more active in communicating, including with strangers.
Began showing interest in letters and words.
Scores on the ADI-R, ADOS, and CARS questionnaires improved.
Language comprehension and speech skills improved.
The patient continues treatment with the exosomal preparation DC-EX-N (intranasal drops).

HEMORRHAGIC STROKE
Patient: MAHMOUD, 71, KUWAIT.
Hemorrhagic stroke in 2023. Coma for 1 year. Tetraplegia (complete loss of motor function and sensation in the arms and legs). Unable to swallow – tube feeding. Frequent pneumonia.
Cell therapy: In 2025, a 3-month course of intravenous infusion of donor bone marrow-derived MSCs and 10 injections of the exosomal preparation DC-EX were administered over 5 months.
RESULTS:
He began to drink from a straw and eat independently;
CT scan showed a marked reduction in the hematoma of the right cerebellar hemisphere and a decrease in subarachnoid hemorrhage;
Pneumonia has not recurred;
He has begun to recognize his children;

The patient continues treatment with the exosomal preparation DC-EX-N (intranasal drops).

NEUROLOGY - spinal cord injury
Patient Mr. Soma, Japan.
Car accident, thoracic spine injury in the spring of 2025, resulting in spinal cord injury. Spinal surgery was performed. Lower paraplegia. Wheelchair use.
Cell therapy: In the fall of 2025, a 3-month course was administered: 2 intravenous infusions of donor bone marrow-derived MSCs, 2 local injections into the spine, and 3 intravenous injections of the exosomal preparation DC-EX.
RESULTS:
•He began sitting without supporting himself with his arms;
•He began drinking and using eye drops;
•He began to feel his abdominal muscles;
•He rode a canoe for the first time, and by the second day, we had practically completed the entire six-month project.
•He is preparing to become an athlete for the Japanese national team and compete at the 2028 Paralympic Games in Los Angeles.

STOMACH CANCER
Patient: Mr. J, 50, USA.
Reason for treatment: Stage 4 gastric adenocarcinoma. After repeated chemotherapy, a significant decrease in red blood cells (65% of normal), hemoglobin (58%), and hematocrit (59%) made further cancer treatment impossible.
Cell therapy: intravenous infusion of 200 million donor bone marrow-derived MSCs.
Result: After 3 days, a significant improvement in blood counts – red blood cells by 37%, hemoglobin by 39%, hematocrit by 43%. Chemotherapy was initiated.

PROSTATE CANCER
Patient R, 64, Australia
Reason for treatment: Prostate adenocarcinoma, stage 2. PSA increased to 11. In November 2024, MRI revealed a 5 mm nodule, indicating high oncologic risk (PI-RADS 5).
Cells therapy: combination therapy with BM-MSC and DOV oncolytic viruses.
Result: After 3 months, PSA decreased to 8.5; no nodule was detected in the prostate, and the oncologic risk decreased to PI-RADS 3.

KNEE JOINT
Patient: Zung, 80, Vietnam
Reason for treatment: Stage 3 knee osteoarthritis for several years. She underwent multiple treatments, including joint injections every 2-3 months, but to no avail.
Cell therapy: local and intravenous BM-MMSC injections, taping.
Result: significant pain reduction within 2 weeks. The results lasted for 1 year.

KNEE JOINT
Patient: Vladimir, 42, Russia.
Reason for treatment: Professional boxer. He suffered from stage 3 post-traumatic osteoarthritis of the knee joints for 5 years. His knee was painful and constantly swollen. He had undergone 4 knee surgeries and was recommended for joint replacement.
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: "My knee stopped swelling and buckling. I can now do squats and jumps on this leg. I no longer feel pain during exercise." The results lasted for 1 year.

KNEE JOINT
Patient: Alexander, 53, Israel
Reason for therapy: "After an injury and surgery, the patient's right knee was bothering him during long walks, while sitting, or while standing. I decided to try MMSC."
Therapy: Local injections of MMSC into the joint.
Result: "The day after the procedure, I felt much better, was able to walk 3 km and sit for 1.5 hours. A year later, I feel well and am pain-free." Seven years later (2024), the results are still there, and I am pain-free.

KNEE JOINT
Patient: Dr. Nikolai, 79, Russia.
Reason for treatment: Stage 3 osteoarthritis, torn menisci. Constant knee pain for four years. I periodically received knee injections 3-4 times a year, but improvement lasted only one month, then had to repeat.
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: About a month after the injection, there was significant improvement – ​​the pain and crunching in my knee disappeared. I began walking normally without limping. The results lasted one year.

ELBOW JOINT
Patient: Mikhail, 52, Russia.
Reason for treatment: "As a result of constant work at the microscope and computer, I developed severe elbow pain. At the clinic, I was diagnosed with epicondylitis. This was interfering with my work and sleep. I underwent treatment—local injections of hormonal and anti-inflammatory medications, PRP—but there was no effect."
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: "Within a week, my pain was practically gone, and I was able to work and sleep normally." The results lasted for one year.

LOW BACK
Patient: Hitomi, 72, Japan
Reasons for treatment: Lumbar osteochondrosis and herniated discs. Lower back pain when bending and walking for more than 5 minutes.
Treatment: Intravenous infusion and local injection of mechenchymal stem cells from bone marrow in combination with Dokar taping.
Results: The next day, she felt better – no pain, and could bend forward. After two weeks, she was able to walk 2 km without pain. Follow-up since 2018 – pain-free.

SHOULDER
Patient F, 58, Japan.
Reason for treatment: I've been swimming since I was young. I swam a lot, especially butterfly. Because I swam butterfly, I put a lot of strain on my shoulder, and it became very painful. As a result, I couldn't move my arm back. I also couldn't lift it up. I couldn't move my arm back, and the pain was intense. Eventually, I almost stopped swimming.
Cell therapy: local injection of the exosomal preparation DC-EX-L, taping.
Result: Within about the first week, the pain almost completely disappeared. After two and a half months, my condition had almost completely returned to normal. As a result, I can now, of course, swim freestyle and butterfly again. I'm now in very good condition and feeling very well. Almost six months have passed since the injection, and I'm doing very well.

ICE-HOCKEY
Patient: Denis, 34, hockey, Russia.
Reason for treatment: Professional hockey player, KHL. Knee injury, underwent two surgeries in Germany. Due to the injury and his age, club management did not want to renew his contract.
Cell therapy: two intravenous and one local injection of MMSCs into the knee (200 and 50 million), taping.
Result: "The knee no longer bothers me. Endurance, recovery, and sleep have improved." Club management extended his contract, and Denis played for three more seasons, despite his age.

Burn on the skin
Patient: Alexander, 52, Russia.
Reason for treatment: Burns to the hands.
Therapy: Applications of the exosomal solution DC-EX-S twice daily for two days.
Result: Skin condition improved within two days.

Rosacea
Patient: Elena, 37, Russia.
Reason for treatment: Rosacea.
Therapy: Localized facial injection of MMSC.
Result: "The injections were painless, and there was no swelling or bruising the next day. The rash on my face disappeared. My face became more hydrated. I really like it."

Rosacea
Patient: Ilya, 40, Ukraine.
Reason for treatment: Rosacea.
Therapy: Local injection of MMSC into the face.
Result: "The rash on my face cleared up within a week. The results lasted for two years."

Rosacea
Patient: Elena, 22, Russia.
Reason for treatment: Rosacea
Therapy: Applications of DC-EX-S exosomal solution twice daily for two weeks.
Result: Skin condition restored after one week.

Melasma
Patient: Elena, 39, Russia
Reason for treatment: Melasma (skin hyperpigmentation). Worsening in the sun. The pigment did not respond to phototherapy or worsened.
Therapy: DC-EX Exosomes - 5 ml, once a month, 8 treatments.
Result: Skin condition restored after 8 months.

Melasma
Patient: Svetlana, 46 years old, Russia
Reasons for treatment: Melasma (skin hyperpigmentation). Worsening effects of sun exposure. Hormonal imbalance, iron deficiency anemia.
Therapy: DC-EX Exosomes - 5 ml, once a month, 4 treatments.
Result: Skin condition restored after 4 months.

Acne.
Patient: Anna, 26 years old, Russia
Reason for treatment: Acne.
Therapy: Laser resurfacing + DC-EX-5 ml exosome application. Followed by daily applications of DC-EX-5 ml exosomes once daily for 10 days.
Result: Skin condition improved after 10 days.